Literature DB >> 1538489

Radical retropubic prostatectomy: morbidity and quality of life. Experience with 620 consecutive cases.

P Leandri1, G Rossignol, J R Gautier, J Ramon.   

Abstract

We describe our experience and complications of radical retropubic prostatectomy. From March 1983 through December 1990, 620 consecutive patients have undergone an anatomical radical retropubic prostatectomy for the treatment of prostatic carcinoma. The surgical technique we used is described. In 167 patients the procedure included preservation of the neurovascular bundles. There were no modifications in the surgical technique during this period. There were no operative deaths. Mean operating time was reduced from 3 hours in the first 100 patients to 1.5 hours in the last 220 patients. The average blood loss was reduced remarkably as well. There were only 3 cases of rectal injury, which were closed primarily and healed completely. One patient died of acute myocardial infarction 12 days after an uneventful operation. This patient accounted for the only perioperative death in our experience. Early complications occurred in 43 patients (6.9%), including only 2 cases (0.3%) of anastomotic urinary leakage. The late complication rate, excluding incontinence and impotence, was 1.3%. No patient was totally incontinent. Among the patients who were followed for 1 year or longer 95% achieved complete urinary control and 5% experienced stress urinary incontinence. Preservation of sexual function in patients who underwent a nerve-sparing operation was achieved in 71%. Our results indicate that radical retropubic prostatectomy can be performed with low morbidity and without affecting the quality of life in the majority of patients.

Entities:  

Mesh:

Year:  1992        PMID: 1538489     DOI: 10.1016/s0022-5347(17)37412-8

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  18 in total

1.  Minimizing complications during retropubic radical prostatectomy - Is ureteral stenting necessary?

Authors:  B Schlenker; C Gratzke; M Seitz; P von Walter; D Tilki; O Reich; D Zaak; C G Stief; M J Bader
Journal:  Eur J Med Res       Date:  2010-03-30       Impact factor: 2.175

2.  Open versus laparoscopic radical prostatectomy.

Authors:  Herbert Lepor
Journal:  Rev Urol       Date:  2005

3.  Selecting candidates for radical prostatectomy.

Authors:  H Lepor
Journal:  Rev Urol       Date:  2000

Review 4.  Oncological and functional results of open, robot-assisted and laparoscopic radical prostatectomy: does surgical approach and surgical experience matter?

Authors:  T R Herrmann; R Rabenalt; J U Stolzenburg; E N Liatsikos; F Imkamp; H Tezval; A J Gross; U Jonas; M Burchardt
Journal:  World J Urol       Date:  2007-03-13       Impact factor: 4.226

5.  Successful repair of iatrogenic rectourinary fistulas using the posterior sagittal transrectal approach (York-Mason): 15-year experience.

Authors:  Fabrizio Dal Moro; Mariangela Mancini; Francesco Pinto; Nicola Zanovello; Pier Francesco Bassi; Francesco Pagano
Journal:  World J Surg       Date:  2006-01       Impact factor: 3.352

Review 6.  Prostate cancer: 6. Surgical treatment of localized disease.

Authors:  S L Goldenberg; E W Ramsey; M A Jewett
Journal:  CMAJ       Date:  1998-11-17       Impact factor: 8.262

7.  Rectourethral fistula following laparoscopic radical prostatectomy.

Authors:  L Chun; M A Abbas
Journal:  Tech Coloproctol       Date:  2011-07-01       Impact factor: 3.781

8.  Venous thromboembolism in urologic surgery: prophylaxis, diagnosis, and treatment.

Authors:  Kevin R Rice; Stephen A Brassell; David G McLeod
Journal:  Rev Urol       Date:  2010

Review 9.  Management of the complications of radical prostatectomy.

Authors:  Penner Schraudenbach; Carlos E Bermejo
Journal:  Curr Urol Rep       Date:  2007-05       Impact factor: 3.092

10.  Prolene (mesh) bulbourethral sling in male incontinence.

Authors:  Rakesh Kapoor; Kamal Jeet Singh; Amit Suri; Pratipal Singh; Anil Mandhani
Journal:  Indian J Urol       Date:  2007-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.